Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration.

Trial Profile

Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2010

At a glance

  • Drugs Cefpirome (Primary) ; Moxifloxacin (Primary)
  • Indications Abscess
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top